- Home
- DXYZ vs RXST Comparison
DXYZ vs RXST Comparison
Compare DXYZ & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DXYZ | RXST |
|---|---|---|
| Founded | N/A | 1997 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.6M | 417.3M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DXYZ | RXST |
|---|---|---|
| Price | $23.26 | $11.76 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $11.30 |
| AVG Volume (30 Days) | N/A | ★ 898.2K |
| Earning Date | N/A | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $142,085,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 10.75 |
| 52 Week Low | N/A | $6.32 |
| 52 Week High | N/A | $46.77 |
Technical Indicators
Market Signals| Indicator | DXYZ | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 70.26 |
| Support Level | $20.80 | $11.20 |
| Resistance Level | $22.28 | $10.12 |
| Average True Range (ATR) | 0.93 | 0.69 |
| MACD | 0.19 | 0.21 |
| Stochastic Oscillator | 78.91 | 88.24 |
Price Performance
Historical ComparisonAbout DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.